ReviewFrontiers in psychology2026
The prospect of suicide biomarkers: from neurobiology to precision prevention.
Review in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of a Nomogram for Estimating the Risk of Suicide Tendencies Among Chinese Middle School Students: A Cross-Sectional Study.Psychology research and behavior management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Suicide remains a global public health crisis, accounting for over 720,000 deaths annually. Despite progress in identifying risk factors and developing theoretical frameworks, suicide continues to be a complex biopsychosocial phenomenon that eludes comprehensive understanding. This review synthesizes current evidence on the neurobiological underpinnings of suicidal behavior, encompassing genetic and epigenetic vulnerabilities, systemic physiological dysregulations, and structural and functional brain alterations. Furthermore, it critically evaluates recent advances in biologically-targeted interventions and assesses the translational potential of biomarker research for precision psychiatry. While these developments provide promising avenues for objective risk stratification and targeted treatments, significant challenges persist in bridging the gap between scientific discovery and clinical implementation. By integrating evidence across these disciplines, this review aims to provide clinicians and researchers with a comprehensive reference to inform clinical practice and guide future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.